Status:
COMPLETED
Cardiovascular Complications and COVID-19 (CovCardioVasc-Study)
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
COVID
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Patients with COVID-19 in the Intensive Care Unit (ICU) or hospitalized with severe form have a poor prognosis (almost 30% rate of death). They present often a high cardiovascular risk profile (almost...
Eligibility Criteria
Inclusion
- \- All consecutive patients with COVID-19 infection admitted to the ICU or hospitalized because of severe form (eg: hypoxia, orthopnea, pneumonitis, kidney insufficiency) will be included
Exclusion
- \- Patients under 18 years
Key Trial Info
Start Date :
February 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
198 Patients enrolled
Trial Details
Trial ID
NCT04335162
Start Date
February 28 2020
End Date
August 31 2021
Last Update
April 3 2025
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Cannes
Cannes, France, 06400
2
CHU de Dijon
Dijon, France
3
Centre Hospitalier de Draguignan
Draguignan, France, 83300
4
Centre Hospitalier de Grasse
Grasse, France, 06130